Farmers & Merchants Bank of Long Beach Closes Equity Investment
LONG BEACH, Calif.–(BUSINESS WIRE)–Farmers & Merchants Bank of Long Beach (“F&M” or the “Bank”) (OTCQX: FMBL) today announced the Bank... Read more.
New Data Show Early Use of Delve Bio’s Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis
Data presented at IDWeek 2025 alongside additional clinical and validation data, education session on the use of metagenomics in central nervous system infections... Read more.
Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million
– Viridian receives $55 million upfront and potential near-term milestones up to $115 million based on positive VRDN-003 topline data and U.S. veligrotug marketing... Read more.
UBS Hires Financial Advisor Michael Shain in Greenville, South Carolina
GREENVILLE, S.C.–(BUSINESS WIRE)–UBS Wealth Management today announced the hiring of Financial Advisor Michael Shain in Greenville, South Carolina. Michael... Read more.
Stoke Therapeutics Presents Two-Year Natural History Data from Patients with Autosomal Dominant Optic Atrophy (ADOA)
– Data provide insights that informed the Phase 1 study of STK-002 as a potential disease-modifying medicine for ADOA, including disease etiology, progression... Read more.
Teledyne FLIR Defense to Deliver Portable Chemical Detectors to US Customs and Border Protection to Aid in Narcotics Crackdown
Company’s Griffin G510x chemical identifier will support CBP efforts to combat drug trafficking and the spread of illegal narcotics across borders; Industry-leading... Read more.
Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)
DALLAS–(BUSINESS WIRE)–AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral... Read more.
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2025
Summit Plans to Submit a BLA in Q4 2025 for Ivonescimab Based on HARMONi Global Phase III Study Results Expansion of Summit’s Global Phase III Development Program... Read more.
TELUS Digital Reminds Shareholders to Vote IN FAVOUR of Arrangement with TELUS Corporation
TELUS Digital’s independent Special Committee unanimously recommends that shareholders vote IN FAVOUR of the Arrangement Proxy voting deadline is October 23, 2025... Read more.
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects RAHWAY, N.J.–(BUSINESS WIRE)–Merck... Read more.